These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21595176)

  • 1. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors].
    Swierkot J; Madej M
    Pol Merkur Lekarski; 2011 Apr; 30(178):283-8. PubMed ID: 21595176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors].
    Swierkot J; Madej M
    Pol Merkur Lekarski; 2011 Apr; 30(178):289-94. PubMed ID: 21595177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in early rheumatoid arthritis.
    de Vries-Bouwstra JK; Dijkmans BA; Breedveld FC
    Rheum Dis Clin North Am; 2005 Nov; 31(4):745-62. PubMed ID: 16287595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it possible to withdraw biologics from therapy in rheumatoid arthritis?
    Tanaka Y; Hirata S
    Clin Ther; 2013 Dec; 35(12):2028-35. PubMed ID: 24290736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics in rheumatoid arthritis.
    Sharma PK; Hota D; Pandhi P
    J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis.
    Tanaka Y
    Curr Opin Rheumatol; 2012 May; 24(3):319-26. PubMed ID: 22388646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugs.
    Pavelka K; Kavanaugh AF; Rubbert-Roth A; Ferraccioli G
    Rheumatology (Oxford); 2012 Jul; 51 Suppl 5():v12-21. PubMed ID: 22718922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective use of TNF antagonists.
    Yocum D
    Arthritis Res Ther; 2004; 6 Suppl 2(Suppl 2):S24-30. PubMed ID: 15228618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
    Schwartzman S; Fleischmann R; Morgan GJ
    Arthritis Res Ther; 2004; 6 Suppl 2(Suppl 2):S3-S11. PubMed ID: 15228615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis.
    Murdaca G; Spanò F; Puppo F
    Expert Opin Drug Saf; 2013 Nov; 12(6):801-4. PubMed ID: 23889669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Daily practice using the guidelines for prevention and treatment of osteoporosis. The effects of anti-TNF therapy on bone and joint manifestations in rheumatoid arthritis].
    Soen S
    Clin Calcium; 2008 Aug; 18(8):1169-75. PubMed ID: 18677056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next stage of RA treatment: is TNF inhibitor-free remission a possible treatment goal?
    Tanaka Y
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii124-7. PubMed ID: 23253919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recapitulation of the round-table discussion--assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritis.
    Furst DE; Keystone E; Maini RN; Smolen JS
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():50-3. PubMed ID: 10646494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current tumor necrosis factor-alpha inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis.
    Liang GC; Cordero M; Dyer A; Chang RW
    J Rheumatol; 2005 Sep; 32(9):1662-5. PubMed ID: 16142857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological therapies in the spondyloarthritides--the current state.
    Braun J; Sieper J
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.